DOI QR코드

DOI QR Code

Strategies to reduce risk factors of non-communicable diseases in South Korea

만성질환 위험요인 감소를 위한 전략과 방향

  • Khang, Young-Ho (Department of Health Policy and Management, Seoul National University College of Medicine, Institute of Health Policy and Management, Seoul National University Medical Research Center)
  • 강영호 (서울대학교 의과대학 의료관리학교실, 서울대학교 의료관리학연구소)
  • Received : 2016.09.01
  • Accepted : 2016.09.28
  • Published : 2016.10.01

Abstract

Objectives: This review is to suggest strategies to reduce risk factors of non-communicable diseases (NCD) in South Korea. Methods: Prior research findings on the burden of NCD and associated risk factors and the effectiveness of intervention programs were reviewed. Strategies regarding the control of NCD risk factors were conceived. Results: The author presented research findings from the Global Burden of Disease study on the burden of non-communicable disease (NCD) and associated risk factors in South Korea. Strengths and limitations of population and high-risk strategies for preventing NCDs were introduced. The author also reviewed the evidence on the effectiveness of multiple cardiovascular risk factor interventions and community-based intervention programs on cardiovascular diseases conducted in industrialized countries. Finally, strategies to reduce NCD risk factors in South Korea were suggested. Conclusions: The evidence-based interventions and the importance of population strategies in NCD prevention were highlighted. The author indicated that strategies employed by unhealthy commodity industries to undermine effective public health policies and programs should be actively monitored. It has been suggested that effective high-risk strategies with ecological models to address social risks rather than medical risks among disadvantaged population should be further developed in South Korea.

Keywords

References

  1. Capewell, S., Graham, H. (2010). Will cardiovascular disease prevention widen health inequalities? PLoS Med, 7(8), e1000320. https://doi.org/10.1371/journal.pmed.1000320
  2. Chapman, S. (2009). The inverse impact law of smoking cessation. Lancet, 373(9665), 701-3. https://doi.org/10.1016/S0140-6736(09)60416-5
  3. Chapman, S., MacKenzie, R. (2010). The Global Research Neglect of Unassisted Smoking Cessation: Causes and Consequences. PLoS Med, 7(2), e1000216. https://doi.org/10.1371/journal.pmed.1000216
  4. Danaei, G, Finucane, MM, Lin, JK, Singh, GM, Paciorek, CJ, Cowan, MJ, ... Ezzati, M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). (2001). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet, 377(9765), 568-77. https://doi.org/10.1016/S0140-6736(10)62036-3
  5. Ebrahim, S., Davey Smith, G. (1998). Health promotion for coronary heart disease: past, present and future. Eur Heart J, 19(12), 1751-7. https://doi.org/10.1053/euhj.1998.1207
  6. Ebrahim, S., Davey Smith, G. (2001). Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol, 30(2), 201-5. https://doi.org/10.1093/ije/30.2.201
  7. Ebrahim, S., Taylor, F., Ward, K., Beswick, A., Burke, M., & Davey Smith, G. (2011). Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev, (1), CD001561.
  8. Emberson, J., Whincup, P., Morris, R., Walker, M., & Ebrahim, S. (2004). Emberson et al. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease European Heart Journal, 25(6), 484-91. https://doi.org/10.1016/j.ehj.2003.11.012
  9. Ezzati, M., & Riboli, E. (2012). Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science, 337(6101), 1482-7. https://doi.org/10.1126/science.1227001
  10. Fortmann, S. P., & Varady, A. N. (2000). Effects of a community-wide health education program on cardiovascular disease morbidity and mortality: the Stanford Five-City Project. Am J Epidemiol, 152(4), 316-23. https://doi.org/10.1093/aje/152.4.316
  11. GBD 2013 DALYs and HALE Collaborators. (2015). Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet, 386(10009), 2145-91. https://doi.org/10.1016/S0140-6736(15)61340-X
  12. GBD 2013 Risk Factors Collaborators. (2015). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386(10010), 2287-323. https://doi.org/10.1016/S0140-6736(15)00128-2
  13. Hajifathalian, K., Ueda, P., Lu, Y., Woodward, M., Ahmadvand, A., Aguilar-Salinas, C. A., ... Danaei, G. (2015). A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol, 3(5), 339-55. https://doi.org/10.1016/S2213-8587(15)00081-9
  14. IAEG-SDGs. (2016, August 28). Report of the Inter-Agency and Expert Group on the Sustainable Development Goal Indicators. UHC Economic and Social Council, 2016 Retrieved from http://unstats.un.org/unsd/statcom/47th-session/documents/2016-2-IAEG-SDGs-Rev1-E.pdf
  15. IHME (Institute for Health Metrics and Evaluation). (2016, August 28). South Korea country profile. Retrieved from http://www.healthdata.org/south-korea
  16. Jorgensen, T., Jacobsen, R. K., Toft, U., Aadahl, M., Glumer, C., Pisinger, C. (2014). Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ, 348, g3617. https://doi.org/10.1136/bmj.g3617
  17. Jousilahti, P., Laatikainen, T., Salomaa, V., Pietilä, A., Vartiainen, E., Puska, P. (2016). 40-Year CHD Mortality Trends and the Role of Risk Factors in Mortality Decline: The North Karelia Project Experience. Glob Heart, 11(2), 207-12. https://doi.org/10.1016/j.gheart.2016.04.004
  18. Kawachi, I. (2014). Why is behavior change so difficult? In L. F. Berkman, I. Kawachi, & M. M. Glymour (Eds.), Social Epidemiology (2nd Ed). (pp. 482-3). New York, NY: Oxford University Press.
  19. Khang, Y. H. (2013). Burden of noncommunicable diseases and national strategies to control them in Korea. J Prev Med Public Health, 46(4), 155-64. https://doi.org/10.3961/jpmph.2013.46.4.155
  20. Kontis, V., Mathers, C. D., Rehm, J., Stevens, G. A., Shield, K. D., Bonita, R., ... Ezzati, M. (2014). Contribution of six risk factors to achieving the $25{\times}25$ non-communicable disease mortality reduction target: a modelling study. Lancet, 384(9941), 427-37. https://doi.org/10.1016/S0140-6736(14)60616-4
  21. Krogsboll, L. T., Jorgensen, K. J., Gronhoj Larsen, C., Gotzsche, P. C. (2012). General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev, 10, CD009009.
  22. Lee, H. Y., Seo, H. J., Jang, B. H., Lee, Y. J., Park, J. E., Son, H. J. Analysis of Korean health care - Gap between evidence and current practice. Seoul, Korea: National Evidence-Based Healthcare Collaborating Agency, 2009.
  23. Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., ... Ezzati, M. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859), 2224-60. https://doi.org/10.1016/S0140-6736(12)61766-8
  24. Lorenc, T., Petticrew, M., Welch, V., & Tugwell, P. (2013). What types of interventions generate inequalities? Evidence from systematic reviews. J Epidemiol Community Health, 67(2), 190-3. https://doi.org/10.1136/jech-2012-201257
  25. MOHW (Ministry of Health and Welfare). 2013 Health and Welfare White Paper. Seoul; Ministry of Health and Welfare, 535.
  26. Moodie, R., Stuckler, D., Monteiro, C., Sheron, N., Neal, B., Thamarangsi, T., Lincoln, P., Casswell, S., on behalf of The Lancet NCD Action Group. (2013). Profits and pandemics: prevention of harmful eff ects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet, 381, 670-79. https://doi.org/10.1016/S0140-6736(12)62089-3
  27. Pennant, M., Davenport, C., Bayliss, S., Greenheld, W., Marshall, T., Hyde, C. (2011). Community programs for the prevention of cardiovascular disease: a systematic review. Am J Epidemiol, 172(5), 501-16. https://doi.org/10.1093/aje/kwq171
  28. Rose, G. (1992). The strategy of preventive medicine. New York, NY: Oxford University Press.
  29. Saquib, N., Saquib, J., & Ioannidis, J. P. (2015). Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials. Int J Epidemiol, 44(1), 264-77. https://doi.org/10.1093/ije/dyu140
  30. Susser, M. (1995). The tribulations of trials-intervention in communities. Am J Public Health, 85(2), 156-8. https://doi.org/10.2105/AJPH.85.2.156
  31. Taubes, G., Kearns Couzens, C. (2016, August 28). Big sugar's sweet little lies. How the industry kept scientists from asking: Does sugar kill? Mother Jones. Retrieved from http://www.motherjones.com/environment/2012/10/sugar-industry-lies-campaign
  32. The COMMIT research group. (1995). Community intervention trial for smoking cessation (COMMIT): II. Changes in adult cigarette smoking prevalence. Am J Public Health, 85(2), 193-200. https://doi.org/10.2105/AJPH.85.2.193
  33. Tunstall-Pedoe, H., Connaghan, J., Woodward, M., Tolonen, H., & Kuulasmaa, K. (2006). Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. BMJ, 332(7542), 629-35. https://doi.org/10.1136/bmj.38753.779005.BE
  34. Webb, T. L., Sheeran, P. (2006). Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull, 132(2), 249-68. https://doi.org/10.1037/0033-2909.132.2.249
  35. WHO (World Health Organization). (2011). Global status report on noncommunicable diseases 2010. Geneva: World Health Organization.
  36. WHO (World Health Organization). (2016, August 28). Final Comprehensive Global Monitoring Framework for NCDs. Retrieved from http://ncdalliance.org/sites/default/files/rfiles/GMF_Final%20Table%20of%20Targets.pdf
  37. Winkleby, M. A. (1994). The future of community-based cardiovascular disease intervention studies. Am J Public Health, 84(9), 1369-72. https://doi.org/10.2105/AJPH.84.9.1369
  38. Yang, S., Khang, Y. H., Harper, S., Davey Smith, G., Leon, D. A., Lynch, J. (2010). Understanding the rapid increase in life expectancy in South Korea. Am J Public Health, 100(5), 896-903. https://doi.org/10.2105/AJPH.2009.160341
  39. Yoon, J,, Oh, I, H,, Seo, H,, Kim, E, J,, Gong, Y, H,, Ock, M,, ... Yoon. S, J. (in press). Disability-adjusted Life Years for 313 Diseases and Injuries: the 2012 Korean Burden of Disease Study. J Kor Med Sci